Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” third-quarter 2025 investor ...

DexCom, Inc. DXCM is scheduled to report third-quarter 2025 resultson Oct. 30, after the closing bell. In the last reported ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Medtronic plc offers stable dividends and consistent cash flow, but growth remains lackluster with revenues plateauing. Read ...

Amid some scrutiny over its latest-generation G7 CGM, Dexcom officials addressed claims on the company's latest earnings call ...

Dietitians are not just end-users of AI tools. They can be cocreators, leaders, and subject matter experts on AI projects. In ...

It's leveraging its expertise to invest across the space, including building AI factories. Brookfield's AI infrastructure investments could drive robust growth and strong returns across its platform.

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

Dexcom has issued a Class I recall for its G6 Android app due to crashes that could cause users to miss critical glucose ...

The Vivo V70 has appeared on Geekbench with the Snapdragon 7 Gen 4, 8GB RAM and Android 16, hinting at an early 2026 launch.

The alleged Poco Pad X1 with Snapdragon 7+ Gen 3, 8GB RAM, and Android 15 appears on Geekbench, possibly a rebranded version of the Xiaomi Pad 7.

Shares of DexCom Inc. DXCM slid 1.03% to $70.33 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.79% to 6,791.69 and the ...